<SEC-DOCUMENT>0001193125-14-298544.txt : 20140806
<SEC-HEADER>0001193125-14-298544.hdr.sgml : 20140806
<ACCEPTANCE-DATETIME>20140806172701
ACCESSION NUMBER:		0001193125-14-298544
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20140806
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20140806
DATE AS OF CHANGE:		20140806

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ORTHOFIX INTERNATIONAL N V
		CENTRAL INDEX KEY:			0000884624
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19961
		FILM NUMBER:		141020994

	BUSINESS ADDRESS:	
		STREET 1:		7 ABRAHAM DE VEERSTRAAT
		STREET 2:		CURACAO
		CITY:			NETHERLANDS ANTILLES
		STATE:			P8
		ZIP:			00000
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d771339d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, DC 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM 8-K
</B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT REPORT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant to Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported): August&nbsp;6, 2014 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Orthofix International N.V. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of Registrant as specified in its charter) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Cura&ccedil;ao</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>0-19961</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>N/A</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(State or other jurisdiction of incorporation)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Commission File Number)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(IRS Employer Identification No.)</B></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>7 Abraham de Veerstraat</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Cura&ccedil;ao</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>N/A</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(Address of principal executive offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Registrant&#146;s telephone number, including area code: <B>011-59-99-465-8525</B> </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (<I>see</I> General Instruction A.2. below): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </TD></TR></TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B>Item&nbsp;2.02.</B></TD>
<TD ALIGN="left" VALIGN="top"><B><U>Results of Operations and Financial Condition</U>. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On August&nbsp;6, 2014, Orthofix
International N.V. (the &#147;<U>Company</U>&#148;) issued a press release regarding, among other things, preliminary net sales results for the fiscal quarter ended June&nbsp;30, 2014 (the &#147;<U>2014 Second Quarter</U>&#148;), and the
Company&#146;s expectation that it will need to file a Form 12b-25 with respect to its Quarterly Report on Form 10-Q for the 2014 Second Quarter. A copy of that press release is furnished herewith as Exhibit 99.1. The information included in this
Current Report on Form 8-K under this Item&nbsp;2.02 (including Exhibit 99.1) shall not be deemed &#147;filed&#148; for the purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended (the &#147;<U>Exchange Act</U>&#148;), or
otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing made by the Company under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by
specific reference in such a filing. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01.</B></TD>
<TD ALIGN="left" VALIGN="top"><B><U>Financial Statements and Exhibits</U>. </B></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top">Exhibits </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">99.1</TD>
<TD ALIGN="left" VALIGN="top">Press release, dated August&nbsp;6, 2014. </TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Orthofix International N.V.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Jeffrey M. Schumm</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jeffrey M. Schumm</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Chief Administrative
Officer, General Counsel and Corporate Secretary</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: August&nbsp;6, 2014 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:39.10pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit&nbsp;No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:39.50pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press release, dated August 6, 2014.</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d771339dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top">


<IMG SRC="g771339g69y83.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Orthofix, International N.V.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">3451 Plano
Parkway</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Lewisville, TX 75056 USA</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Tel 214 937 2000</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">Orthofix.com</P></TD></TR>
</TABLE> <P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman"><B>News Release </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CONTACT:
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mark Quick </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investor Relations </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tel 214 937 2924 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">markquick@orthofix.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Orthofix Announces Delay of Form 10-Q Filing and Provides </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Preliminary Second Quarter 2014 Net Sales Results </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">LEWISVILLE, Texas, August&nbsp;6, 2014 &#150; Orthofix International N.V. (NASDAQ: OFIX) today announced that it is delaying the release of its financial
results for the fiscal quarter ended June&nbsp;30, 2014. The Company requires additional time to evaluate certain items primarily related to entries contained in the previous restatement of its prior periods&#146; financial results. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">President and Chief Executive Officer Brad Mason stated, &#147;While it is unfortunate we have discovered items that require additional analysis in certain
previous restatement entries, considering the complexity of our prior restatement, the identification of potential technical errors is understandable. We look forward to finalizing the analysis as quickly as possible and bringing the investment
community up to date on the recent performance of the business.&#148; Mr.&nbsp;Mason further stated, &#147;There may be changes to historical net sales and net income totals, but we expect that the factors causing these revisions, if any, will have
little or no effect on the underlying performance of the business going forward.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, the Company announced preliminary net sales results
for the fiscal quarter ended June&nbsp;30, 2014. The Company expects to report: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Net sales of $101.3 million </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">BioStim net sales of $39.8 million </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Biologics net sales of $13.9 million </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Extremity Fixation net sales of $27.3 million </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Spine Fixation net sales of $20.2 million </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To provide adequate time to fully review and correct identified
errors if any, and to consider and evaluate their level of materiality, the Company intends to file a Form 12b-25 (Notification of Late Filing) with the Securities and Exchange Commission (SEC) for the quarter ended June&nbsp;30, 2014. The Company
is proceeding with the objective of filing its second quarter Form 10-Q, as well as issuing a press release and hosting a conference call regarding second quarter financial results, no later than the end of August 2014. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top">


<IMG SRC="g771339g69y83.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Orthofix, International N.V.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">3451 Plano
Parkway</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Lewisville, TX 75056 USA</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Tel 214 937 2000</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">Orthofix.com</P></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About&nbsp;Orthofix </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Orthofix International N.V.&nbsp;is a diversified, global medical device company focused on improving patients&#146; lives by providing superior reconstructive
and regenerative orthopedic and spine solutions to physicians worldwide. Headquartered in&nbsp;Lewisville, Texas, the Company has four strategic business units that include BioStim, Biologics, Extremity Fixation and Spine
Fixation.&nbsp;Orthofix&nbsp;products are widely distributed via the Company&#146;s sales representatives, distributors and its subsidiaries. In addition,&nbsp;Orthofix&nbsp;is collaborating on research and development activities with leading
clinical organizations such as the&nbsp;Musculoskeletal Transplant Foundation, the&nbsp;Orthopedic Research and Education Foundation&nbsp;and the&nbsp;Texas Scottish Rite Hospital for Children. For more information, please
visit&nbsp;www.orthofix.com. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This communication contains certain forward-looking statements under the Private Securities Litigation Reform Act of 1995. These forward-looking statements,
which may include, but are not limited to, statements concerning the projections, financial condition, results of operations and businesses of Orthofix and its subsidiaries and are based on management&#146;s current expectations and estimates and
involve risks and uncertainties that could cause actual results or outcomes to differ materially from those contemplated by the forward-looking statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The forward-looking statements in this release do not constitute guarantees or promises of future performance. Factors that could cause or contribute to such
differences may include, but are not limited to, risks relating to the uncertain results and timing of our analysis primarily related to entries contained in the previous restatement of our prior periods&#146; financial results and our expected
inability to file our quarterly report on Form 10-Q for the fiscal quarter ended June&nbsp;30, 2014 before its August&nbsp;11, 2014 due date (including our expected filing of a Form 12b-25 (Notification of Late Filing) with the SEC with respect to
such fiscal quarter), as well how these matters may impact our expenses, liquidity, legal liability, borrowing ability, product sales, relationships with customers, suppliers, strategic partners and third party reimbursement providers, ongoing
compliance obligations under our corporate integrity agreement with the Office of Inspector General of the Department of Health and Human Services, deferred prosecution agreement with the U.S. Department of Justice and consent decree with the SEC,
ability to remain in compliance with covenants and other obligations under our senior secured credit agreement, the cost and nature of our insurance coverage, continued listing of our securities on the Nasdaq Stock Market, and other factors
described in our annual report on Form 10-K for the fiscal year ended December&nbsp;31, 2013 and other subsequent periodic reports filed by the Company with the SEC. Existing and prospective investors are cautioned not to place undue reliance on
these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to update or revise the information contained in this press release. </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g771339g69y83.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g771339g69y83.jpg
M_]C_X``02D9)1@`!`0$!+`$L``#_X1%617AI9@``34T`*@````@`!P$.``(`
M```&```(;@$2``,````!``$```$Q``(````>```(=`$R``(````4```(DH=I
M``0````!```(IIR;``$````,```10NH<``<```@,````8@`````<Z@````@`
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M`````````````````````````````````````%!R:6YT`$%D;V)E(%!H;W1O
M<VAO<"!#4S,@36%C:6YT;W-H`#(P,#DZ,#$Z,3(@,#DZ,#(Z,#$```B0`P`"
M````%```$1B0!``"````%```$2R2D0`"`````S`P``"2D@`"`````S`P``"@
M`0`#`````0`!``"@`@`$`````0```GF@`P`$`````0```&/J'``'```(#```
M"0P`````'.H````(````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M```````````````````````````````````````````````````````R,#`Y
M.C`Q.C$R(#`Y.C`R.C`Q`#(P,#DZ,#$Z,3(@,#DZ,#(Z,#$```!0`'(`:0!N
M`'0```#_X@Q824-#7U!23T9)3$4``0$```Q(3&EN;P(0``!M;G1R4D="(%A9
M6B`'S@`"``D`!@`Q``!A8W-P35-&5`````!)14,@<U)'0@``````````````
M`0``]M8``0````#3+4A0("``````````````````````````````````````
M`````````````````````````!%C<')T```!4````#-D97-C```!A````&QW
M='!T```!\````!1B:W!T```"!````!1R6%E:```"&````!1G6%E:```"+```
M`!1B6%E:```"0````!1D;6YD```"5````'!D;61D```"Q````(AV=65D```#
M3````(9V:65W```#U````"1L=6UI```#^````!1M96%S```$#````"1T96-H
M```$,`````QR5%)#```$/```"`QG5%)#```$/```"`QB5%)#```$/```"`QT
M97AT`````$-O<'ER:6=H="`H8RD@,3DY."!(97=L971T+5!A8VMA<F0@0V]M
M<&%N>0``9&5S8P`````````2<U)'0B!)14,V,3DV-BTR+C$`````````````
M`!)S4D="($E%0S8Q.38V+3(N,0``````````````````````````````````
M````````````````````````````````6%E:(````````/-1``$````!%LQ8
M65H@`````````````````````%A96B````````!OH@``./4```.06%E:(```
M`````&*9``"WA0``&-I865H@````````)*````^$``"VSV1E<V,`````````
M%DE%0R!H='1P.B\O=W=W+FEE8RYC:```````````````%DE%0R!H='1P.B\O
M=W=W+FEE8RYC:```````````````````````````````````````````````
M``````````````!D97-C`````````"Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@
M4D="(&-O;&]U<B!S<&%C92`M('-21T(``````````````"Y)14,@-C$Y-C8M
M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92`M('-21T(`````````````
M````````````````9&5S8P`````````L4F5F97)E;F-E(%9I97=I;F<@0V]N
M9&ET:6]N(&EN($E%0S8Q.38V+3(N,0``````````````+%)E9F5R96YC92!6
M:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$`````````````````
M`````````````````'9I97<``````!.D_@`47RX`$,\4``/MS``$$PL``UR>
M`````5A96B```````$P)5@!0````5Q_G;65A<P`````````!````````````
M`````````````H\````"<VEG(`````!#4E0@8W5R=@````````0`````!0`*
M``\`%``9`!X`(P`H`"T`,@`W`#L`0`!%`$H`3P!4`%D`7@!C`&@`;0!R`'<`
M?`"!`(8`BP"0`)4`F@"?`*0`J0"N`+(`MP"\`,$`Q@#+`-``U0#;`.``Y0#K
M`/``]@#[`0$!!P$-`1,!&0$?`24!*P$R`3@!/@%%`4P!4@%9`6`!9P%N`74!
M?`&#`8L!D@&:`:$!J0&Q`;D!P0')`=$!V0'A`>D!\@'Z`@,"#`(4`AT")@(O
M`C@"00)+`E0"70)G`G$">@*$`HX"F`*B`JP"M@+!`LL"U0+@`NL"]0,``PL#
M%@,A`RT#.`-#`T\#6@-F`W(#?@.*`Y8#H@.N`[H#QP/3`^`#[`/Y!`8$$P0@
M!"T$.P1(!%4$8P1Q!'X$C`2:!*@$M@3$!-,$X03P!/X%#04<!2L%.@5)!5@%
M9P5W!88%E@6F!;4%Q075!>4%]@8&!A8&)P8W!D@&609J!GL&C`:=!J\&P`;1
M!N,&]0<'!QD'*P<]!T\'80=T!X8'F0>L![\'T@?E!_@("P@?"#((1@A:"&X(
M@@B6"*H(O@C2".<(^PD0"24).@E/"60)>0F/":0)N@G/">4)^PH1"B<*/0I4
M"FH*@0J8"JX*Q0K<"O,+"PLB"SD+40MI"X`+F`NP"\@+X0OY#!(,*@Q##%P,
M=0R.#*<,P`S9#/,-#0TF#4`-6@UT#8X-J0W##=X-^`X3#BX.20YD#G\.FPZV
M#M(.[@\)#R4/00]>#WH/E@^S#\\/[!`)$"800Q!A$'X0FQ"Y$-<0]1$3$3$1
M3Q%M$8P1JA')$>@2!Q(F$D429!*$$J,2PQ+C$P,3(Q-#$V,3@Q.D$\43Y10&
M%"<4211J%(L4K13.%/`5$A4T%585>!6;%;T5X!8#%B86219L%H\6LA;6%OH7
M'1=!%V47B1>N%](7]Q@;&$`891B*&*\8U1CZ&2`911EK&9$9MQG=&@0:*AI1
M&G<:GAK%&NP;%!L[&V,;BANR&]H<`APJ'%(<>QRC',P<]1T>'4<=<!V9'<,=
M[!X6'D`>:AZ4'KX>Z1\3'SX?:1^4'[\?ZB`5($$@;""8(,0@\"$<(4@A=2&A
M(<XA^R(G(E4B@B*O(MTC"B,X(V8CE"/"(_`D'R1-)'PDJR3:)0DE."5H)9<E
MQR7W)B<F5R:')K<FZ"<8)TDG>B>K)]PH#2@_*'$HHBC4*08I."EK*9TIT"H"
M*C4J:"J;*L\K`BLV*VDKG2O1+`4L.2QN+*(LURT,+4$M=BVK+>$N%BY,+H(N
MMR[N+R0O6B^1+\<O_C`U,&PPI##;,1(Q2C&",;HQ\C(J,F,RFS+4,PTS1C-_
M,[@S\30K-&4TGC38-1,U336'-<(U_38W-G(VKC;I-R0W8#><-]<X%#A0.(PX
MR#D%.4(Y?SF\.?DZ-CIT.K(Z[SLM.VL[JCOH/"<\93RD/.,](CUA/:$]X#X@
M/F`^H#[@/R$_83^B/^)`(T!D0*9`YT$I06I!K$'N0C!"<D*U0O=#.D-]0\!$
M`T1'1(I$SD42155%FD7>1B)&9T:K1O!'-4=[1\!(!4A+2)%(UTD=26-)J4GP
M2C=*?4K$2PQ+4TN:2^),*DQR3+I-`DU*39--W$XE3FY.MT\`3TE/DT_=4"=0
M<5"[40914%&;4>92,5)\4L=3$U-?4ZI3]E1"5(]4VU4H5755PE8/5EQ6J5;W
M5T17DE?@6"]8?5C+61I9:5FX6@=:5EJF6O5;15N56^5<-5R&7-9=)UUX7<E>
M&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A]6))8IQB\&-#8Y=CZV1`9)1DZ64]
M99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#:9II\6I(:I]J]VM/:Z=K_VQ7;*]M
M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q.G&5<?!R2W*F<P%S77.X=!1T<'3,
M=2AUA77A=CYVFW;X=U9WLW@1>&YXS'DJ>8EYYWI&>J5[!'MC>\)\(7R!?.%]
M07VA?@%^8G["?R-_A'_E@$>`J($*@6N!S8(P@I*"](-7@[J$'82`A..%1X6K
MA@Z&<H;7ASN'GX@$B&F(SHDSB9F)_HIDBLJ+,(N6B_R,8XS*C3&-F(W_CF:.
MSH\VCYZ0!I!ND-:1/Y&HDA&2>I+CDTV3MI0@E(J4])5?E<F6-):?EPJ7=9?@
MF$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY`GJZ?'9^+G_J@::#8H4>A
MMJ(FHI:C!J-VH^:D5J3'I3BEJ:8:IHNF_:=NI^"H4JC$J3>IJ:H<JH^K`JMU
MJ^FL7*S0K42MN*XMKJ&O%J^+L`"P=;#JL6"QUK)+LL*S.+.NM"6TG+43M8JV
M`;9YMO"W:+?@N%FXT;E*N<*Z.[JUNRZ[I[PAO)N]%;V/O@J^A+[_OWJ_]<!P
MP.S!9\'CPE_"V\-8P]3$4<3.Q4O%R,9&QL/'0<>_R#W(O,DZR;G*.,JWRS;+
MMLPUS+7--<VUSC;.ML\WS[C0.="ZT3S1OM(_TL'31-/&U$G4R]5.U='65=;8
MUUS7X-ADV.C9;-GQVG;:^]N`W`7<BMT0W9;>'-ZBWRG?K^`VX+WA1.',XE/B
MV^-CX^OD<^3\Y83F#>:6YQ_GJ>@RZ+SI1NG0ZEOJY>MPZ_OLANT1[9SN*.ZT
M[T#OS/!8\.7Q<O'_\HSS&?.G]#3TPO50]=[V;?;[]XKX&?BH^3CYQ_I7^N?[
M=_P'_)C]*?VZ_DO^W/]M____X0P!:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O
M,2XP+P`\/WAP86-K970@8F5G:6X])^^[OR<@:60])U<U33!-<$-E:&E(>G)E
M4WI.5&-Z:V,Y9"<_/@T*/'@Z>&UP;65T82!X;6QN<SIX/2)A9&]B93IN<SIM
M971A+R(^/')D9CI21$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q
M.3DY+S`R+S(R+7)D9BUS>6YT87@M;G,C(CX\<F1F.D1E<V-R:7!T:6]N(')D
M9CIA8F]U=#TB=75I9#IF868U8F1D-2UB83-D+3$Q9&$M860S,2UD,S-D-S4Q
M.#)F,6(B('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP
M+R(^/'AM<#I#<F5A=&]R5&]O;#Y!9&]B92!0:&]T;W-H;W`@0U,S($UA8VEN
M=&]S:#PO>&UP.D-R96%T;W)4;V]L/CQX;7`Z0W)E871E1&%T93XR,#`Y+3`Q
M+3$R5#`Y.C`R.C`Q/"]X;7`Z0W)E871E1&%T93X\+W)D9CI$97-C<FEP=&EO
M;CX\<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB=75I9#IF868U8F1D-2UB
M83-D+3$Q9&$M860S,2UD,S-D-S4Q.#)F,6(B('AM;&YS.F1C/2)H='1P.B\O
M<'5R;"YO<F<O9&,O96QE;65N=',O,2XQ+R(O/CQR9&8Z1&5S8W)I<'1I;VX@
M<F1F.F%B;W5T/2)U=6ED.F9A9C5B9&0U+6)A,V0M,3%D82UA9#,Q+60S,V0W
M-3$X,F8Q8B(@>&UL;G,Z9&,](FAT='`Z+R]P=7)L+F]R9R]D8R]E;&5M96YT
M<R\Q+C$O(CX\9&,Z=&ET;&4^/')D9CI!;'0@>&UL;G,Z<F1F/2)H='1P.B\O
M=W=W+G<S+F]R9R\Q.3DY+S`R+S(R+7)D9BUS>6YT87@M;G,C(CX\<F1F.FQI
M('AM;#IL86YG/2)X+61E9F%U;'0B/E!R:6YT/"]R9&8Z;&D^/"]R9&8Z06QT
M/@T*"0D)/"]D8SIT:71L93X\9&,Z9&5S8W)I<'1I;VX^/')D9CI!;'0@>&UL
M;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S`R+S(R+7)D9BUS>6YT
M87@M;G,C(CX\<F1F.FQI('AM;#IL86YG/2)X+61E9F%U;'0B/E!R:6YT/"]R
M9&8Z;&D^/"]R9&8Z06QT/@T*"0D)/"]D8SID97-C<FEP=&EO;CX\+W)D9CI$
M97-C<FEP=&EO;CX\+W)D9CI21$8^/"]X.GAM<&UE=&$^#0H@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@
M("`@("`@("`@("`@(#P_>'!A8VME="!E;F0])W<G/S[_VP!#``$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0("`0$"`0$!`@("`@("`@("
M`0("`@("`@("`@+_VP!#`0$!`0$!`0$!`0$"`0$!`@("`@("`@("`@("`@("
M`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@+_P``1"``R`3T#
M`2(``A$!`Q$!_\0`'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`
MM1```@$#`P($`P4%!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*Q
MP152T?`D,V)R@@D*%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA9
M6F-D969G:&EJ<W1U=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*S
MM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ
M_\0`'P$``P$!`0$!`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#
M!`<%!`0``0)W``$"`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1
M"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI
M:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZ
MPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1
M`Q$`/P#^_BOQG_;=_P""WO[)7[(T^K>"O"%]_P`-'?&C39I;.Z\!_#C7+&'P
MKX;U"UO;>WO;'QY\3A:WEGH5]''_`&FAL].M=:U*"\TW[)J5CIZRK<+^O7BG
M2/#.N^'=9TKQGI^BZMX3O=-NXO$6F^)+>RO/#M[HYA=M0@URSU)6MKK2C;+)
MYZ7"M"T8;S%*YK\B?&7_``4]_8/\>_'[X9_L+?#GPKX/_:6G^+'BRS^''BZ3
M3='\+7OP#\,:!)::BVH6EQJ^K:;<V/Q$NXXK&R$&G:59W6E7"731/K%O<P?9
M9/N>!LJPN88^MB<;PKC>+,!ED)5\31PM=82E3HTXN<ZF)Q/LJC4.6,[4U/#2
MDXI0KMRY3X'C[-\7EN74<+@.+<!PAF&:SAA\-7Q>'>,K5:]62A"GAL,JM).?
M/*%ZDH8J$%)N=#ECS'\BW[67_!5']M3]L'5K[_A//BSJO@CP'<1/:VWPB^$E
MWJ_@3X<PV<UOIL5S;ZO86FK2WWC<RW.FK<[_`!!?ZJUM/>W*Z?\`8K27[*OQ
M3\.?BM\5/@_K<GB7X2_$SX@?"WQ'+`]K)X@^'/C'Q%X(UN2TD5DDM'U7PWJ5
MM.ULRR2!D,FTB1@1@D'^PS_@H]_P0.^$_P`4O"_B;XK?L4>'M.^%?QET^"36
M)/@[8W<&E_"GXE_9O/FO-(\-V=[(MO\`#'Q=/`84T_R)+?PU)+90VEW9Z6MW
M<:Y:?QBZMI.K>']7U;P_K^E:EH6O:#J5[HVN:)K-C<Z9J^C:QIES+9:EI6JZ
M;>Q)-I^I6U[!/#/!,B2PRPM'(JNK*/[W\,^).`>+.'9X?A'+Z.7X3"*,,3E\
MJ%*G.DY+1UJ<>:-:%1J3C6O-59*?,_:*I%?YX>*G"_B+P=Q+#$\99G7S+&8Q
MRJ87,HUZM2%91:4E1J2Y949T[Q4J'+!TDX\D?9.$I?TT_P#!/#_@X'^('A37
M=$^%/[=-XWCWP-JEYIFE:5\>=-TFSLO&?@2)D6P,WQ`T;0[..'QSX8C`LI9K
MZVMX]=MECO;FX_X2":>&&V_L*TS4]-UO3=/UG1M0L=6TC5[&TU/2M5TR[M[_
M`$W4]-O[>.ZL=0T^^M)'BO;&:UEBDBEB=HY(Y%=&96!/^3[7]D'_``;I_MPZ
MY\2O`OC3]C'XCZY?:SK_`,(-#C\>?!F^U*2XO+QOA++J-AHGB3P8UW_9X6*P
M\/\`B75M!DTU;J]GN7LO&S:?9Q0Z9H,,47X?X\>#N58#*Z_&W">!AE_U.2>/
MPM)<M%TIN,%B:%**Y:4J<W%5H02INFW5M!TZCJ?O7T>_&O-\QS:AP)Q?CYYD
M\;&2R_%UI<U9581E-X:O5D^:K&I!2]A4J-U%42H\TU4IJG_3A117X(_\%9?^
M#AS]B?\`X)3:Q=?"7Q'%K_[0'[4HT2RUI?@%\,=0TJS;P?!K%I#J7AZ;XR>/
M=0,UK\,XM0TJ:*[M;2.SUC7GLK^PU$Z$-*U&SOYOX_/[3/WNHK_-4\<?\'J_
M_!0;Q7XUO+;X%?L@?LH>&O#^JZD(?"GA#QQ8_&WXQ>-8H9=JP:?>>(O!WQ*\
M'P>(M2,F[$EMH5B&W!1;`C)@\8_\'??_``6<^%TNGO\`%7]B_P#9)\!6^I<V
M*>,?V?\`]JOP3+J2C>3_`&?/XC_:/59^(Y>4CD^X>.#0!_I945_##^Q-_P`'
MJOPB\:^(?"_@C]O3]F/4_@I;ZB+/3M8^.OP+\0:A\1/`^G:M>ZM9VK:QK_P?
MUO38]?\`#/@JTTJ>]N;N72M9\8:N38+%9Z/=M/B'^V_P!\0/`_Q6\$>$_B7\
M-/%GA_QY\/O'?A_2_%7@SQGX4U6SUSPWXG\-ZW:17^DZWHFKV$KPZAIUQ9S1
M21R1N597]<B@#KZ*_F)_X*C?\'3/[$O_``3O^)GC#]GOX=^"_%/[7W[1'P^U
M0:'X_P##/@/Q-HW@KX3^`/$=I-)#X@\$^+OC!>Z=JSGQ]IK"..^T[1M`UJ'3
M[U+G2=6O=,UBPO;"#^=CQO\`\'N'[:=_XAO+GX;_`+'/[+WA3PH[$Z?HOC?7
M/BO\0?$-JF]B%O/$^@^*/#-M?-L*#*:1;@E2V`"%4`_TG:*_S6/"?_![;^W!
M9ZY:7'CK]D']E3Q'X:0_Z?I/A/4/B[X+URY7>AQ:>(=8\;:_;V1\L2#+Z7<<
MNK8PI5OZ+?\`@F+_`,'07[+7_!1W5/%'P?U7X9:_^S!^U';^#_'/B[X>_#?Q
MCXKL?B+\//B?#X-\+7_B>YTKP?\`$O3=&T.XN_%<.GZ5JMU=Z3?:)I;-8V#3
M:;>ZA*+F&T`/Z>J*_P`S,?\`!['_`,%#\#/[+W[%Y.!DC1/C@`3W(!^-!P,^
MYI?^(V/_`(*'_P#1KO[&'_@D^.'_`,^>@#_3+HK_`#-/^(V/_@H?_P!&N_L8
M?^"3XX?_`#YZ:W_!['_P41*L$_9>_8N5RI",VA_'%U5L':60?&I2R@XR`PST
MR.M`'^F;17\.?_!9/_@Z"_;(_P""<7_!17X\_L=_";X#_LS>-?`7PIL_A-<Z
M)XE^(FE_%.Y\7Z@_C_X,_#_XD:HNJS>&OB;IUDZPZOXMOH+?R;.(BVMXA(9)
M0\C_`-+'_!'3]MCXC?\`!17_`()Q_LZ_MD?%GPQX*\&?$#XQ-\7O[>\-?#NW
MUVT\':8OP^^._P`3_A9I`TB#Q+KFI7J-+H7@C3)[DS7LVZ[N9VB$4+1PQ@'Z
M:445_FN^._\`@]&_X*#^%_&OC+PQ8_LQ_L;3VGAWQ3XAT&SN+O1/C:]Q-;Z1
MJUYI]O-<^3\945IFCMT9]BHI8G:%&``#_2BHKY=_:;_;(_9W_8M_9_O_`-I+
M]JGXG^'OA)\,-(M=(2[UG51>W=YJ_B'6;1[G3O"G@_PYI<%QJ/B[Q1=+;WKV
MVG:=;W5VT%A<7+1K:VMS/%_$9^U7_P`'N7B-M9U+1OV(OV,=!MM!L]27^ROB
M)^U)XKU+5-3U_2C:Q>8+SX/?"G4;&/PK>K?&<(Z^-]722%$9H89&:-`#_05H
MK_-5\/?\'='_``6T\8>';CQCX1_8D_91\3^#[9IQ/XI\/?LW?M:ZYX=MOL[8
MG6XUW3/VDY+6-HSP^Z1=IZ@=*Z7X)?\`![G^UGHVOM)^T=^QC^SM\1_"\L"Q
M):?!+Q1\2O@KK]E<M*-]\VH^.]9\?V^IP+#NQ:"UM&=@,WD8/`!_I"T5^6__
M``3(_P""P7[%_P#P5=\!ZMXD_9J\8:OIGC[P?:077Q)^!7Q'T^T\._%KX?P7
M5[/86>J7^E6.HWECXC\+W,T430:MHM_J-DGV^WMKZ2QU-I-/A]$_X*+?\%.O
MV1_^"6_P<L/C'^U9XVO]*A\2ZE=Z'\.?AOX-TZW\2_%;XJ:[IUM%>ZKIO@3P
MI/J-I%/;V5G/:OJ&IZC>:=HNG-J-C!?:E;W6I:=!=@'Z"45_GL_&7_@^$\;W
M?]I6/[/?[`/A70?*NKV/1_$_QE^-^K^+?MMD)"NG76I>!/!'@31/[,NC$`\U
MO%XCNT5I#&ERP3S7^6O^(V/_`(*'_P#1KO[&'_@D^.'_`,^>@#_3+HK_`#-X
M_P#@]A_X*'/(B']E[]C`!G521HOQPR`S`$\_&?T-?I=_P6(_X.BOVS?^"=/_
M``4<_:,_8W^%7P'_`&8O&OP_^#S?"+_A'O$OQ!TGXJS^,=17X@_`CX7_`!3U
M4:S/X<^*&GV4K0Z[XWU2"W,%E!BTMK=9!),LDTH!_<U17\S'[+O_``5*_P""
MGG[;_P#P1M7_`(*`_LN_`/\`9B\8?M1:#\1?B;::Y^SW>:'\6)O#OC[X=?#O
M4+W3[RP^%J67Q-34&^*AC6UN;:RNKRX@U;[/-86<<-]-:1R_@%\!_P#@]9_:
M=@^-W@+3?VJ?V5?@/:?`MO%$>D_%I_@[8?$W2/BSX?T"X$^GWNM>%(O&OQ'U
M'3[W6-+O9(+V32[RVB_M.+3)M,6^TN:Z34K0`_T9**\V^#WQ@^&/[0'PN\!_
M&OX,>--$^(GPL^)OAK3?%_@;QIX>G>?2M?T#5H1-:W4(FCCFL[E3OBN;6YBA
MN[.YMYK2\@@NH9H4_DY_X+:_\'3V@_L!_'2']E?]B7P9\+/VB?C%\/M2OK;]
MH[QAX\NO$FH?"SX::[;)):I\'M!'@KQ!IL_BGXH6EV3+XCG2_&G>&I;5-`F2
M_P#$#ZW:>%P#^P^BOY(?^"5?_!:C_@JA^W%\+?%'[6GQI_9@_9:^&O[).D^.
MOAY\"/AEJ6D:?\8_#'BS]HC]I'XZ?%?P;^SW\*O"'A'Q1K7CW7H?`?P;T?XN
M_$KP@_CSQT?#?B=]-L;2]TKPYX9\2:W%JD>@?<?[+_\`P6%^,'QR^'#_`!$\
M)_LG_$[]I3PWJESX0U#3O$GP\\/?!7]F2\\(VOQ"^#GPK^._AOP5XO\``WQ<
M_;(\70:SK</PX^,?@&[;5],\4![N75[E+GPOH>GP:)JWB@`_F9_;O_X*H_M1
M?MP^(?$NB:]XUO\`P3\!FUG4AX6^#'@QIO#WAN?0%OHWT:3X@26UR]S\0=>^
MRZ?I<TYU.YGL+>_CFN-(T_2XYF@KYO\`V)/B)I_PE_;(_99^)&M:[:>&?#GA
M'X^_"G4_%OB"_<QV6D>#!XUT:W\97UY(,F.T3PO/JYE8`[4+'%<?^TU\*(O@
M5^T?\>O@Q;)?KI_PM^,'Q%\":/-J4%Q;7E]H/ACQ;JVDZ!JCQ7(WM%=Z-:V-
MU%)EA-%=I*CNCJ[>&NNX8XQWS[^X_P`\U_JUE60\/4^%Z>3Y'@J>79%F.%Y8
MPHTXPO3Q-%)U)*WOU)PES3G/FE.5W)N[/\A,WXBXDJ<6SSK/\=4S+/LKQ:E.
M5:I*?+5PU:_LXNZY*4)PY80ARQA'2"21_K)U_&I_P<7?L5:3\-OB+X(_;*\`
M:/;:7X?^,VJ'P#\7K*QCAMK6+XM:?I5YJWAKQ8L,FJLTM[XA\(:1K,5XEI8P
M6T5S\/VO[R:;4=<E=_WV_P""37[:NE?MJ_LA^!?$>IZ[%J'QC^&6G:7\-?C?
MI]S?QW>NOXMT*P2TT[QS?H+&UW6?B?1[6#6$EA@^QQWUUJ>E03SS:3=,NK_P
M5T^$-O\`&C_@G1^U-X?==/COO"7PZNOB[I-_?64-W-I]U\'+VT^)=_\`V7)(
MA:PU*\\/^&=:TP31%7$.NS1$F*61&_@3P_S#-_#/Q5P.`Q]\-*EC%EN/A=J$
MZ%>I&E*>UYTXMT\71DE[_)3DKQE9_P"B?B-EN3^*GA%C\PR]1Q<*V!_M3+ZF
MCG3KT*4JT8)[0J22J82M%ZPYZD96E&Z_SCZ_0G_@E)\6+KX-_P#!1+]DWQ/;
MQ7-S#X@^*VD?"K4+2"ZEMHKBR^,\-S\*#->JCA;JUL[KQC:ZAY4FY3+H\;JO
MF(A7\]J^P/\`@GMX8USQ=^WA^QOH_A[3KG5-0B_:7^"^OSVUI&998=#\)?$'
MP_XK\3ZFZCI:V7AO1=6O)VXVPV$C=J_T"XKHX?$<+\24,6D\+6P&,C4N[+V<
ML/44[NZLN5N[NK;W/\X^#J^)PW%W"V(P;:Q=',<%*ERJ\N>.)IN-EK=N5ERV
M=]K.]C_1:_:D^-47[-G[,O[1?[14VBCQ'#\`O@3\7?C5+X>-Y_9PUZ+X6?#_
M`,0^.9-%.H>3)]A%TNA&#SO+D\KS]^QMNT_X8WQ"\>_$O]H/XM^,/B5X\U?6
M/B#\7/C+X^UGQ;XIUF>+[5K?B[QWXZUV?4M2N5M;2(!KR[UK4I/+@@C5%,RP
MPQJ@1!_N'?MP?"#Q/^T'^Q9^U]\!/!(LF\9_&_\`9=^/_P`(/"*ZE=K8:<WB
M?XE?"CQ;X,T`7]\X*V5D=5UJT\V4@B--SD86O\-#P_K6O?#OQIHGB*S@.G^*
M/`WBC3=:M+;5+-B;'7O#.K0WT$&HZ?<!23%J%BBS0N%/R,C`'-?Y/'^PA_M,
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M_)G_`.#H_P#X)E_";_@G?^W9X5\1?L[>$(?`/P$_:G\`7_Q.T#P+I<`M?"7@
M+XDZ#XBN-$^)_@[P+9^:_P#9GA$+>>$-9MK!-EKIC>-Y=,TV"UTJSL;6'])_
M^#<S_@I-\5O@I_P1_P#^"R/@)O%E]9O^QE\%M<^/?[,VMWERVK2^"?'/QG\#
M_$_1+?P_I=EK5R]IIOAB#XO^#/!NM6]A#%Y4VI^.==NY(9KB\99OG_\`X/)?
MVQ_A[\>OVZ?@M^S=\./$NA^+8/V0?AEXGTSXC:CHCM<IH'QC^*_B#3=1\5^`
M;O44'D7VH:5X2\$_#U[M+=Y5L;_6[S3+IH]1LKVUMOGK_@CU\'_%EO\`\$6?
M^#@GX_7^AW%MX&UCX)_!?X/^%?$DBVQM=9\6>'/$&O\`C3Q_H=FX<S1SZ;H_
MBKX:SW(94C=?%EKL:5XW$(!^`'[+WPS\(?'W]ISX(?"OXL?%70/A!\/OBA\7
M/!GASXH?&7QOXCT30-&^'W@C7/$=FGCOQYJWB#Q;?06,=S8^'I-6O(OMMPD=
MS=010,^Z89_UB?V3?C/_`,&YW[$/P[T;X;?LU_M+_P#!,3X?:9I>FZ?8:CXE
MA^/7[/&I?$3QG<:<CB+6OB!\0]1\3R:OXUUQI9KA_M%_=S>2)O)M4M[9(H$_
MRP_^"=O[*FE_MP_MM?LX_LF:WXRU#X?:5\=?B':^"+[QII>D6^OZAX=AN--U
M*_.H6NCW=];1ZA*&L%7RWGB&)"=W&#_;VW_!CS\%RK!/^"@WQ/5R#M9O@'X4
M=0V."RCXE*6&>HR,^HH`^W/^"W?_``45_P""#'Q"_8'_`&E/`VN?%']C_P#:
M5^-7B#X.?$G0_P!G/1_A#IG@OXR^.O#GQT\1^$=2L_AUXO\`#OC7P+9W<?PV
M73O%=SI-_J.J3:I8(;+3;JS9=0EG72KS^`__`((N^"/B-\0?^"LW_!.W0OA;
MIVKZGXGL?VN_@=XSOHM%=X[FT\!_#OQUI'C_`.*6KW;(XW:+9?#+PUXNN]11
MMR2V%E<1,DBN8W\(_;N_8A^.G_!._P#:?^)/[*W[0>A+IGC;P#J(DTK7M/6X
MD\*?$;P1J3RR^$OB3X%U*>)#JGA+5M.C\V$LJ7-G<Q76E:E!9ZMI]_96W^F7
M_P`&S/PE_P""3&J?LBZ1^TQ^P)\(E\(_&_6])@^'?[2]]\3?%K_$WX_^`/'%
MI]FU+6_`%]XOO;.U@L/A_?30Z=J&E3^'M)T'3/$5A::=>ZEID.M6-W9:<`?T
MF?\`"(^%/^A8\/?^"73?_D:O\]7_`(/?-)TO2_BC_P`$\%TS3=/TY9O`/[1I
MF6PL[>S$I3Q%\(`AE%O&OF$!FQG.-QQUK_1+K_/$_P"#XO\`Y*E_P3L_[$#]
MH_\`]2+X/4`=A_P8XZ5IFJ+_`,%04U/3;#44A;]BAHDO[.WNUB9A^UN&:-;B
M-@C$``D8SBO[ZO\`A$?"9Z^&/#W_`()=-_\`D:OX)/\`@QC_`.<HO_=DW_OW
M%?W^4`?Y#/\`P=._\IS/VRO^P7^S7_ZRM\%*_IW_`.""'_!=O_@E+^QI_P`$
MF?V4?V;?VE/VL++X:?&OX<?\+T_X33P3+\'OV@?%4FB?\)A^TI\8_'GAS=KW
M@?X4:GI=]]I\)^*-"NQ]EO9O*%^(9O+N(Y8H_P"8C_@Z=_Y3F?ME?]@O]FO_
M`-96^"E?MQ_P1A_X-B?^"?W_``4-_P"":G[-O[87QN^)7[67A_XG_%[_`(7#
M_P`)/I'PS^(7PIT/P1:?\(!\?/BG\+]%_L72_$OP0UB]M?,\/>"M)EN?.U&X
MWW<T\D?DQ.D$0!_2#_Q$]?\`!#'_`*/JT[_Q'W]JW_YQ5?Y%/Q)U73]=^(OC
M[7-)N1>:5K/C7Q5JNF7BQ3P+=:?J.NW]W97(AN8DDA#VTT;;9$1UW8=58$#_
M`$V/^(+?_@E1_P!%C_;M_P##L?`S_P"AJK_,>\>Z'9^&/'7C3PUISW,FG^'O
M%GB/0[&2\DCENY+/2=8O+"U>ZEAAC22Y,%NA=EC12Q)5%!"@`_JZ_P"#O_\`
M:_\`%OQ4_;F^%7[(UGKUY'\,/V6/@9X`U:]\*QRF.QN/C%\8M!MO&NN^)KV.
M)P+Z=?AM>?#6SLQ.K-9`:B;9D74KD/\`7?\`P:#_`/!)?X`?M$Z/\6_^"A?[
M27@+PW\6E^%OQ5A^#7[/?@+QE80:WX0\/^._#OA?P[XX\=?%/7_"6J:?)9^)
MM:M;/QOX(M/#$L[RVVEWEOK5^;)]5@T74-,_-W_@[7^`GB3X7?\`!4^+XM7U
MCJ3>%OVF/V=?@AX]\/:U)8W":-)JO@'P?9_!?Q)X<LM3,?DW>JV47P]T&^N[
M=7,UM#XOL)942.[MVD_?#_@RF_:Z^&>I?LW?M)_L.ZCJ]CI?QC\(_&?4?VCO
M#>C7E_:P7GC+X:>._!GP]\!:W<^'].;$M\_A_P`4^`K4ZK*"5BC^(6D*%&7:
M@#^X6***"*.""..&&&-(H88D6.***-0D<<<:`!(U0```````#%?S$_\`!S1_
MP2>_9\_:R_8.^//[66B>`/"W@_\`:O\`V6?A]KWQHTCXM:%IEEH>N>._AYX!
MM&\0?$CX=_$N]T[3FD\;:.?!%CKUYH9O-UUI6MZ?;&SO;/3K_7+;4?Z>J_$3
M_@XA_:Z^&/[)O_!)G]KE?'.M647BK]H7X2>-_P!F;X4^$?MEK%KOC'Q=\:O#
MM_X%U)]'L[AP;FTT7PGK>NZ[J,G"Q67A^1%8W4]I#,`?Y<O_``2(_;!\4_L,
M?\%&_P!D_P#:!T'Q'J?A_P`/:7\7?!_@_P"+<6G1I=KX@^"/C_7+#PG\6-`O
M-)N)%@U<OX/U/4;FR2?Y;;5M+T_4(&AO+*VN(?U(_P"#M3]I/QM\:?\`@K_\
M3_A-K-[<KX$_94^'WPJ^%/P]T6/4-0DTM9/%_P`/O#7QF\:^)WTB:X:VLO$E
M[XD^(KZ==7-O&DEWIW@K1H[AG^QPK'^)O[`GP`\2_M4?MM_LI?L\^$[;4Y]5
M^+/Q\^&'A.YNM)L)]2NM!\.77BS3+CQCXOGM;:"5AI6B>$+;7-8OI3&R6]EH
M=Q<2CRXG(_1'_@Y1)/\`P6[_`&],G/\`Q6GPM'/H/V?_`(2@#\J`/WR_X-S?
M&W_!`K]D']D_PG\=/VOOC7^S+J'[=/Q%\4^+O$&M)\9_"%_XK\3?L_\`AO0/
M$FM>$/`W@_P)'J6@:E8^'+^]\/Z5)X@O-8TV*RU6['Q!_LN[N)[+3;-5_J;M
M?^"]O_!$NRA2VLOV[OV>K2WC&(X+6S\2V\*#T2*+P@%4?05_+1_P2'_X-;/V
M%O\`@H'_`,$Z?V:_VO\`XM_&W]K/PI\1/C+I7Q"OO$N@?#KQ9\'M/\%Z?-X2
M^+OQ`\`:>NAV7B;X*:I?6\<FD>%-/EF%QJ%R6N9YF0QQ,D,?Z2?\04?_``30
M_P"CCOVZ/_"X^`/_`-#K0!_2-^R9^W=^Q/\`MU0^/+C]D;XX_#SXZP_#&3PU
M#X^D\&6^HLOAB7QBNO/X934?[6T>VYO$\,:^8O+W_P#(,DW;?EW?Y:?_``='
M?\IU_P!N;_NV;_UCS]GVO]'G_@DY_P`$6OV:_P#@CY9_':R_9W^(WQQ^($7[
M0-S\-KKQ<WQHUOP%K,FE/\+XO'<6AKX</@;X>:`+=)U^(&K_`&O[2+HN;2V\
MDP[9?-_SAO\`@Z._Y3K_`+<W_=LW_K'G[/M`']QO_!HU_P`H9/AG_P!EO^/?
M_J9"OSG_`.#EO_@W3;XZQ>.O^"C'[!/@AW^.=M#>>*/VGOV>/"NGS32?'&T@
M19-3^,?PGT2QB;9\:;>W22?Q%H=N@3QG!$^K:<B^,XKRV\;_`*,?\&C7_*&3
MX9_]EO\`CW_ZF0J3_@X+_P""_'@K_@F!\.M3_9__`&?]6T3QC^WE\1O#4C:!
MIX33];T7]G3P[K=HZV/Q3^(.G7<4UM>^*GAE$_AKP[=Q21WCK'JNKP-HR06>
MM`'^?]^PW_P7._;R_P""?_[*?[0/[(GP,\>Q6WP\^,NDWG_"":UJ9NY/%_[.
M7C+7K_3X?&?C7X,:S#.K:)=ZOX9358);60/#8:Q<6OB726L-4BU!M6^A/^""
M?_!$+XD?\%;?CM/X\^)%OXB\*?L4_"3Q/:/\;_B<3>6-]\1_$@2#61\$OAKK
M$J?\3+QK>V=S93Z[?0NX\-:1J\-]=NFH:GH%GJ?PS^R__P`$V/\`@H%_P4Q\
M)_M9?M,?!'X;^+OC9!\$M+UCXI_%[Q?JU_J&H>+_`(J>.]=UBWUWQ'X/^'YN
MHI[KXK_&^XT?4]?\376E0,UY<V>DR1"6;7]9\-:1KWZS?\&\'_!P/XF_X)H>
M.=*_9A_:>UG7_%O[!'Q!\0MMN52]US7OV5O%WB'41+??$CP9IEO#-=:Q\++N
M_N)[CQ9X8LT>X5[B?Q/X<MYM<35-%\7`'^GRO[./P2@^!>D_LU:5\/M)\-_!
M/PYX6\.>#_"7@GP?<:IX,3P1I7@R33KKP/?>`=?\*7]GJG@/Q;H.KZ-HNIZ#
MKVCWUEKFAZSHEEK6E:C::M9VU[%\?6?_``2._86U"VM[?XI_!;P=\<TTG3O#
MF@^$K?XC^`?A3I.A^!O#/A#PEX>\`>&-!\(^#/A)\//"^@Z=]D\!>#O`^@_V
MI+I<^O7>@_#SPSH=_JUWI'ACP]9:9^B/A;Q3X9\<^&?#GC7P5XCT+QAX-\8:
M%I'BGPEXM\+:OI_B#PSXI\,^(-/M]6T'Q'X<U[2;B:UUO0K[2KNTN;.\MI9;
M>YM[J.:&1XW5CNT`?Q??\'&W[(>I^`_CGX5_;&\.:?)+X*^-NGZ)X$^(EXMS
M/<-I7Q:\%Z`VG>'YKB*XD"65AJ_PTT#3(K.*V4H+CX?:I/<^7)=0^?\`S85_
MJ9_'OX'?#O\`:4^#WC[X&_%;27UGP%\1M#?1-=M8)4M[ZV:.YMM2TG6M(NI(
M9%L]=T[6['3=0L)VCE6&\TR"5HI%0HW\#O[6W_!'O]L_]F/XJ#P9X=^%'CKX
M^^!_$FLZE9_#;XC_``A\':UXO@\1V%I$M]##XF\.>'8+R\\!>)4TMS)<VE^/
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MQ8Z+93);!9+7P_)?W$UGJ2M%KNE7L;QK]2?\%@Q\._V?/V5/`?\`P3._8H^"
MFFK\1?VE=;TC6KCX1?![PA+K_C!_AK\,Y-+UK4_&^MZ?X?O)=<UGQ=JNM^!/
M#5J-<U6WU.35M,\&^)GO;_SM,:5/GO$',?#KQ`XZX8P/#;EC^)\-BZ#Q.98=
MPA@88+#5%6Q$L14DK8GZO0IU)TZM)Q@E:+Q$XJ-)?3>&V6>)?ASX?<58[BB,
M,!PKB<)76$RS$QG/,)X[%4W1PT,/2@^;"_6,14IPJT:RE4<KR6&A)RJ/^+^O
MZ9/^#=']BS6O&'Q=U[]MCQEH]W9>"/A39Z[X(^$%S=;[9?$OQ,\3Z1-HOB[7
M-/$.HJUUI.B>!]6U*PF^T6DEG<WWCB,V=Q]MT2\CA[_]A[_@W,\0:G-H_C_]
MNOQ,?#FG0W$%['\`?AQKEK>ZYJ"VUZCO8?$/XDZ3--::383Q6TL<UGX<EN[F
M6VU-)8/$.EWD31+_`%:?#3X:>`O@YX"\*_"_X7^%=)\$^`/!.D6^A^&/#&B0
M&#3]+TZW+OM4N[27=Y+<23SW5U.\MU>75U-=74TUS-+*^_C/XX9'B,DS+A'@
M_&?VEB\R3H8K&4M</3P\KJM2HU+VKSK1_=2G!2HJE.?+4<[<O-X'>`F?X;/L
MLXSXTP7]EX3*Y+$83!5?]YJ8F-G1JUZ5KT(49?O8PFXUW6A3YJ<87YNYK^-O
M_@M9_P`&J'AS]M_XL>,/VL_V&_'W@OX)?'WXC:SJ/B;XQ?"WXD1ZM9_!WXH>
M+=4E^VZM\0M#\0^%]&O[_P"'GCW4+TWL^KQMINI:;KM_J(U!VT6\_M&[U7^R
M2BOXR/[B/\I?X0?\$Z?^#HS_`()07&J:G^S1\+OVF?A_H.OWMY=:IX>^`?CK
MX7?M"?#_`,2ZG);V%G)XCUKX+>%_$_B?3[K7OL6F6,$&I:GX>348K>W\B&9(
M69&]J\4?%W_@\@_:?TZX^$VM:'^WSH=EXBA2"XO-#^!'@+]E*40175NYB;XM
M^%?AYX-FT-7D9%E`UJW\^`RQ2^9;><M?Z?U%`'^7S^QA_P`&=_\`P48^-?C.
MQU/]LSQ!\/\`]D+X:6^LAO%<+>,?#'QL^-.O6+6\E]))X.T/X:ZWJ/AM6N+M
M5M);S5_$]M-8M=F^32M66'[)/_9E^V7_`,$Q[;X5_P#!#CX\?\$W?^"=/PB/
MB'6+OX0VO@?X<^#=7\6>%=&\1_$'Q-KGCKPWJOCGQGXR\=^,M6T;2I_&E_"?
M$&K7=S<W%A9>?&EEI]M:645CIT7[J44`?YDW_!(+_@WM_P""OW[+G_!2_P#8
MY_:"^.O[(O\`P@WPB^%7Q=L?%'CWQ;_POS]F'Q-_8.A0Z-K%I)??V#X/^-6H
M:GJF+B[MU\JRLKB8^9D1D!B/]-FBB@#\&O\`@OA_P1H\'?\`!6;]F"7_`(0Z
MRTCP]^V'\$[#5=>_9W\?W4D.GP:^)5%UKOP5\<WT@"2^"M>^SQ_9+F5E?0M;
MAM-3AF6P?6[#5?Y+?^"2/_!+K_@Y`_X)/_M7^'/CU\./V'[[Q'\-]=-EX6_:
M"^#+_M3_`+'=OH7Q=^&3W+27-@PF_:`:/2O'&E2SRZCX;UA%$VGZA$UO.;G1
M=1UK2]2_TMZ*`*6F74]]INGWUUIE]HMS>6-I=7&CZG)ITNI:3/<01S3:9J$N
MCZA=VDM]!([12M:W5S;-)$Q@N)HBLC?QO_\`!U1_P2D_;Z_X*1^/OV,=:_8N
M^`O_``N;3/A/X0^->E^/[K_A:7P7^'?]@W_B[6OAO=^'H/)^*_Q&T*35?M%O
MH&K-NLDN4B^R8G:-I(@_]EM%`'\@7_!J5_P2X_;L_P"":_\`PWG_`,-K?`S_
M`(4O_P`+H_X9<_X5I_Q<WX._$;_A)?\`A7/_``T5_P`)E_R2;X@Z[_8_V/\`
MX3OPI_R$/LOVC^U?]%\_R+GR?Z_:**`/\Y+_`(+[?\$&_P#@J[^VO_P59_:8
M_:3_`&9/V5?^%E_!7X@6'P0@\(>-/^%Y?LW>#?[7E\(?`#X7^"?$2_\`".?$
M#XPZ5JUA]G\3^'=9M<W5A`)OL?G0&6WDBFD_KO\`^""O[+GQV_8N_P""3W[*
M?[-'[2_@;_A6OQM^&O\`PO/_`(37P5_PDW@[QC_8O_"8_M)_&+Q_X<_XJ/P!
MXAU72-1^T^$O%6@W?^B7\_D_;_(G\JYBFAC_`%^HH`*_R./B1_P;$?\`!<?7
M_B'X]UW2?V(?M6E:UXT\4ZMIEU_PTI^R%!]IT_4M<OKRSG\BY^/R20[[::-M
MDB*Z[L.JL"!_KCT4`?E9_P`%/?\`@DU^SO\`\%7OV7M&^!GQXAOO"'COP/:-
MK/P7^-?AFULKWQK\&_'%UI5C9:C<6=O/,D/BCP7J0TZPM_$&@3SQ6VK6UA;R
MP76G:O8:/K.F?P"?&#_@UE_X+8_L;?%FT\>_LFII'QKD\%W6H^)?`GQN_9I^
M..C_``=^)?AF.TEU&VL;H:-\0/%/A?7?#OCF325$DEKX<NM=C3^T_LMMJEZ_
MF"O]4ZB@#_,9@_:R_P"#S#P18CP9'X5_;JO8-'@CT\7D_P"Q;\*OB!?31I;Q
MHLA\>77P(U*YUR?RPNZY.HW$C2;F>4R[S7SQK_\`P0U_X.._^"G/Q0T;XF?M
M4^!_B+>:AJNHS:"OQ._:Z^.7@S0M(^'>EW-X+N]CTWX:6WB6_P#$'A'P3'<W
M#SBR\->$6M69I&L[*63<M?ZMM%`'\VW_``0[_P"#=7X,_P#!)VXN_CK\2_%N
MF?M!?ME^(O#G_"/_`/"P+?1IM,^'OP6T+5K.$>*?#/P;TG5"UW=ZM?W!GM-0
M\6:@EMJ5]I4$>GZ?IGAZTOM>M=8_FE_X+>?\$!/^"MO[7W_!4S]K?]H[]G;]
MDW_A8?P9^)WB?P%J/@?QE_PO?]FCPE_;EGHOP@^'GA;4YO\`A'O'/QETS5=-
M\K7="U6#;>6-N[_9?-C5X7CD?_2CHH`_)K_@AG^S-\;OV.O^"5?[)G[-W[1W
M@G_A77QI^&6B_%"T\;^#/^$D\(^+O[$N/$7QQ^)WC#1H_P#A(O`FO:II.I>=
MX<\0Z/<YM+ZX6/[9Y,I2>.6)/UEHHH`*_P`X/_@O5_P05_X*P_MH_P#!6+]J
MS]I?]FC]E/\`X65\$OB5_P`*,_X0KQK_`,+S_9M\'?VU_P`(=^S;\'?`'B/_
M`(ISQ_\`&+2M7T[[-XM\*Z]:?Z780>=]@\^#S;:6&:3_`$?**`/Y-/\`@GA\
M"_\`@KK_`,$P_P#@AWI/[/WP:_8</Q"_;ZU'XI_&0^'?!6K_`!N_9DA\"_"?
M2/&.N-J&C_%/QIXBU'XVV^E^+H(K,E['1-*OKNYN+U8X]4%A9B1Y/Y</A[_P
M:_\`_!;W]J[]JO2=<_;)^'4_PKT/XN_$&]\3?'O]J#XB?';X!_%W6='M;Y[K
M6O%'B63PK\._C#JVM^,_%MVL,EII5E%;0V<FI:A90ZA?Z/I(NM2LO]5JB@#Y
MI_9"_9(^!?[#7[/7PZ_9D_9T\(Q>$/AA\-M(33]/AD:&YUWQ%JTY$^O>,_&.
MKPVT/]O>,M5U-I[S4;PQQK)-<%((;>UC@MH?XK/^#@+_`(-?OC9\9_VA)OVO
M/^"8'PYT3QO>_&_Q+?WW[07[.@\8?#WX:2>%_B!J$%WJNH?&3X?:U\1O$NBZ
M-=^%-<O89SK^CO?QZG8:_J4>HZ7#J>F:O?0^%_[Z:*`/X[/^#=#X*_\`!=?_
M`()]7D'[(/[:O[(FO:C^Q3K%QJ>I>`O'TG[1?[,'C+6OV9?$=PEUJ=]::;H'
MA[XX7^J:W\*-8U(NUSI.G6L\VEZK?OJNGVQ6]U9)_P"Q.BB@`HHHH`*^0?V5
M=`T*36/VCOB`^BZ2_CSQ%^T7\4_"WB#QL^FV;>+M=\,>`_$MYI7@?PYK/B0P
M_;-3T'1M+GGMM)LYYGM].MYGALXX8V*DHKZ/)O\`D4\5?]@E'_U.PI\SG?\`
MR.>$?^PNO_Z@8H^OJ***^</I@HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
LH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`/_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
